A team of researchers from Université Paris-Saclay and Université Paris
FDA warns 17 companies about illegal Alzheimer disease products
(HealthDay)—A number of warning/advisory letters have been issued to 17
GPs and pharmacists don’t have time to involve patients in medication reviews
GPs and pharmacists struggle to find the time to involve
Poor whites bear the brunt of U.S. opioid crisis, studies find
(HealthDay)—America’s ongoing opioid epidemic has struck poor whites harder than
Mixed results on early human testing of iron chelation after brain bleed
A drug that removes excess iron and toxins from the
BDNF–VEGF interplay key to rapid antidepressant actions
A study by researchers at Yale University reveals a complex
What is fentanyl? 10 things to know about the potentially deadly drug
In 2016, the powerful drug fentanyl claimed the life of
Firsthand accounts indicate fentanyl test strips are effective in reducing overdose risk
Fentanyl is a synthetic opioid so potent that a miniscule
Exelixis Announces U.S. FDA Approval of Cabometyx (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma
ALAMEDA, Calif.–(BUSINESS WIRE)–Jan. 14, 2019– Exelixis, Inc. (NASDAQ:EXEL) today announced
Rising drug costs can be traced to price hikes for older, brand-name medicine
Anyone keeping tabs on how much they spend at the